首页> 外文期刊>Psychosomatics >Guidelines for the Management of Pregnant Women With Substance Use Disorders
【24h】

Guidelines for the Management of Pregnant Women With Substance Use Disorders

机译:患有物质使用障碍的孕妇管理指南

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Women of reproductive potential with substance use disorders, especially those who are pregnant, present many clinical challenges to healthcare providers, including comorbid psychiatric disorders, a history of trauma and abuse, avoidance of or poor access to prenatal care, fear of legal consequences, and countertransference reactions. Methods: In November 2013, members of the Women's Mental Health Special Interest Group of the Academy of Psychosomatic Medicine presented a Workshop reviewing substance abuse in pregnancy, highlighting the specific contributions that psychosomatic medicine specialists can make in the care of these patients. The discussion focused on epidemiology; maternal and fetal risks; and screening and treatment considerations for tobacco, alcohol, cannabis, opioids, benzodiazepines, stimulants, and several other substances. Objective: Our purpose in publishing this review is to provide clinicians and educators with the most up-to-date summary in this field to better engage these patients in care and break the intergenerational cycle of abuse and addiction.
机译:背景:具有物质使用障碍的具有生殖潜力的妇女,特别是怀孕的妇女,对医疗保健提供者提出了许多临床挑战,包括合并症精神病,外伤和虐待史,避免或难以获得产前保健,担心法律后果和反转移反应。方法:2013年11月,心身医学科学院妇女心理健康特别兴趣小组的成员举办了一个研讨会,回顾怀孕期间的药物滥用情况,强调了心身医学专家在照顾这些患者方面可以做出的具体贡献。讨论的重点是流行病学;产妇和胎儿的风险;以及烟草,酒精,大麻,阿片类药物,苯并二氮杂卓,兴奋剂和其他几种物质的筛选和治疗注意事项。目的:我们发布此评价的目的是为临床医生和教育工作者提供该领域的最新摘要,以更好地让这些患者参与护理工作,并打破虐待和成瘾的代际循环。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号